Notable Buzzers: Novavax, Inc. (NVAX), Microsoft Corporation (MSFT)

However a year ago for the same quarter the company has reported $-0.21 EPS. The firm now has a hold rating on the biopharmaceutical company's stock.

Whereas they predicted High and Low Earnings Estimate as $-0.14 and $-0.18 respectively.

NVAX has been the subject of a number of other research reports. Chardan Capital reaffirmed a hold rating and set a $1.50 price objective on shares of Novavax in a research report on Tuesday, February 28th. Furthermore on 12/16/16 Cantor Fitzgerald "Initiates Coverage On" the stock to Neutral at $2.

Taking a broader look brokerage firms' analysts on the street with an expectant view have Novavax Inc (NASDAQ:NVAX) high price target of $2 and with a conservative view have low price target of $1.5. BidaskClub raised shares of Novavax from a "sell" rating to a "hold" rating in a report on Monday, August 14th. Finally, Citigroup Inc. raised Novavax from a "neutral" rating to a "buy" rating and set a $2.00 target price on the stock in a research report on Tuesday, October 31st.

In terms of Buy, Sell or Hold recommendations, Novavax Inc (NASDAQ:NVAX) has analysts' mean recommendation of 2.4. The stock now has a consensus rating of "Hold" and a consensus target price of $3.12.

Wall Street analysts are predicting that Novavax Inc (NASDAQ:NVAX) will report earnings per share of $-0.16 in their quarterly report. The volume of NVAX witnessed a shift from 7.53 million shares, based on a 50-day average, to 4.42 million shares. For the current quarter Novavax Inc (NASDAQ:NVAX) has high EPS estimates of $-0.14 in contradiction of low EPS estimates of $-0.18. The company has a quick ratio of 3.31, a current ratio of 3.31 and a debt-to-equity ratio of -4.28.

Novavax, Inc. (NVAX) has the market capitalization of $431.92 Million. The biopharmaceutical company reported ($0.15) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.16) by $0.01. Novavax had a negative return on equity of 787.38% and a negative net margin of 726.35%.


According to 6 analysts, the Average Revenue Estimate for the current Fiscal quarter is $7.87 Million and the Low Revenue estimate is $6 Million, while the High Revenue estimate is $10.3 Million. The company beat the analyst EPS Estimate with the difference of $0.02. The company's revenue for the quarter was up 158.5% compared to the same quarter previous year. Canada Pension Plan Investment Board acquired a new position in Novavax during the first quarter worth about $157,000. Voya Investment Management LLC boosted its stake in Novavax by 18.6% during the 2nd quarter.

The company's ATR (Average True Range) is 1.05.

Recent insider trends for Novavax, Inc.

For the Current Quarter, the growth estimate for Novavax, Inc.is 23.8%, while for the Next Quarter the stock growth estimate is -75%. Nationwide Fund Advisors lifted its stake in Novavax by 555.1% in the 2nd quarter. MSFT has risen 5.89% in the 1-month period. Following the completion of the purchase, the insider now directly owns 228,279 shares of the company's stock, valued at approximately $257,955.27.

In other news, Director James F. Young sold 175,000 shares of the company's stock in a transaction dated Thursday, August 31st. (NVAX)'s shares. The total value of these holdings, in millions, is $182. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Stanley C. Erck acquired 100,000 shares of the company's stock in a transaction on Thursday, November 9th. The stock was bought at an average price of $1.13 per share, for a total transaction of $113,000.00. Insider ownership decreased by a total of 65000 shares, which suggests that NVAX's key executives are feeling less optimistic about the outlook for the stock. The disclosure for this purchase can be found here.

TRADEMARK VIOLATION NOTICE: "Novavax, Inc".

The company P/E (price to earnings) ratio is 0 and Forward P/E ratio is 0.

Related:

Comments

Latest news

Scientists successfully grew earthworms in Martian soil simulant!
In earlier experiments, researchers found that worms prove helpful in conditions when water would not easily penetrate the soil. Worms are very important for a healthy soil, not only on Earth but also in future indoor gardens on Mars or the Moon .

Ohio State Rallies Past Michigan; JT Barrett Injured in Sideline Incident
Does that explain the slow start? Mike Weber sealed it for Ohio State with a 25-yard touchdown run with 1 minute 44 seconds left. It had 233 in the second half and scored 17 unanswered points with backup quarterback Dwayne Haskins replacing the injured J.T.

IN teacher caught allegedly using cocaine in classroom
Dyer Police Chief David Hein said in a statement that the Dyer Police Department K-9 narcotics unit was requested to assist St. WGN reports school officials contacted police about Cox and the possibility that she possessed drugs on school property.

Chelsea Offered World Class Player In January
Dortmund crossed out Aubameyang for the Stuttgart counter game due to disciplinary problems. And it appears the club, as well as other European teams, have been put on alert.

Rebel Wilson opens up about defamation case
Wilson explained her experiences of people calling her a liar, a fake, and someone who is inauthentic and disingenuous in general. Rebel Wilson has opened up about her multi-million dollar payout after winning a defamation suit against publisher Bauer Media.

Other news